Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
GHTC sent a letter welcoming Dr. Robert Redfield as the new Centers for Disease Control and Prevention (CDC) director and urging him to prioritize global health R&D at CDC.
GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.
Late last week, USAID Administrator Rajiv Shah released his second annual letter, outlining major issues and initiatives that have shaped the agency since its inception 50 years ago.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
